Significance of the presence of metabolic syndrome in patients with asymptomatic arteriosclerosis affecting the aorta and the cerebral, extra-cranial carotid and coronary arteries

Internal Medicine

Volumn 52, Issue 5, 2013, Pages 523-527

  Ohnuki, Tomohide ^a   Takahashi, Wakoh ^a   Ohnuki, Youichi ^a   Kawada, Shiaki ^b   Takizawa, Shunya ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HIMEDIC Imaging Center   (Japan)

Author keywords

Atherosclerosis; Cerebral small vessel disease; Healthy subject; Metabolic syndrome; Primary prevention

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AORTA ATHEROSCLEROSIS; ARTERY LESION; ARTICLE; BODY MASS; BRAIN ATHEROSCLEROSIS; BRAIN INFARCTION; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY CALCIFICATION; DISEASE ASSOCIATION; ECHOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; RISK FACTOR; VASCULAR DISEASE;

ADULT; AORTA, ABDOMINAL; ARTERIOSCLEROSIS; ASYMPTOMATIC DISEASES; CAROTID ARTERIES; CEREBRAL ARTERIES; CORONARY VESSELS; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED;

EID: 84874755712     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.52.8858     Document Type: Article

References (34)

1. Reaven GM. Role of insulin resistance in human disease. Diabetes 37: 1595-1607, 1988.
2. Kaplan NM. The deadly quartet: upper body obesity, glucose intolerance, hypertriglyceridemia and hypertension. Arch intern Med 149: 1514-1590, 1989.
3. Ninomiya JK, L'italien G, Criqui MH, Whyte JL, Gamst A, Chen RS. Association of the metabolic syndrome with history of myocardial infarction and stroke in the third national health and nutrition examination survey. Circulation 109: 42-46, 2003.
4. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middleaged men. JAMA 288: 2709-2716, 2002.
5. Koren-Morag N, Goldbourt U, Tanne D. Relation between the metabolic syndrome and ischemic stroke or transient ischemic attack. A prospective cohort study in patients with atherosclerotic cardiovascular disease. Stroke 36: 1366-1371, 2005.
6. Milionis HJ, Rizos E, Goudevenos J, Sefeiadis K, Mikhailidis DP, Elisaf MS. Components of the metabolic syndrome and risk for first-ever acute ischemic nonembolic stroke in elderly subjects. Stroke 36: 1372-1376, 2005.
7. Kurl S, Laukkanen JA, Niskanen L, et al. Metabolic syndrome and the risk of stroke in middle-aged men. Stroke 37: 806-811, 2006.
8. Najarian RM, Sullivan LM, Kannel WB, Wilson PW, D'Aqostino RB, Wolf PA. Metabolic syndrome compared with type2 diabetes mellitus as a risk factor for stroke. The framingham offspring study. Arch Intern Med 166: 106-111, 2006.
9. Hulthe J, Bokemark L, Wikstrand J, Faqerberg B. The metabolic syndrome, LDL particle size, and atherosclerosis: the Atherosclerosis and Insulin Resistance (AIR) study. Arterioscler Thromb Vasc Biol 20: 2140-2147, 2000.
10. Iglseder B, Cip P, Malaimare L, Ladumer G, Paulweber B. The metabolic syndrome is a stronger risk factor for early carotid atherosclerosis in women than in men. Stroke 36: 1212-1217, 2005.
11. Takahashi W, Ohnuki T, Honma K, Kawada S, Takagi S. The significance of multiple risk factors for early carotid atherosclerosis in Japanese subjects. Intern Med 46: 1679-1684, 2007.
12. Exective Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285: 2486-2497, 2001.
13. Grundy SM, Cleeman JI, Noel Bairey Merz C, et al. NCEP report implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines. Circulation 110: 227-239, 2004.
14. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. WHO, Geneva, 1999.
15. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/ National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112: 2735-2752, 2005.
16. International Diabetes Federation. Worldwide definition of the metabolic syndrome. IDF, Brussels, 2011.
17. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome, a joint interim statement of the international diabetes federation task foece on epidemiology and prevention: National heart, lung and blood institute: American heart association: World heart federation: Internationar atherosclerosis society: and International association for the study of obesity. Circulation 120: 1640-1645, 2009.
18. Hansen H, Siegrist M, Neidig M, et al. Retinal vessel diameter, obesity and metabolic risk factors in school children (JuvenTUM 3). Atherosclerosis 221: 242-248, 2012.
19. Zanchetti A, Hennig M, Baurecht H, et al. Prevalence and incidence of the metabolic syndrome in the European Lacidipine Study on Atherosclerosis (ELSA) and its relation with carotid initima-media theckness. J Hypertens 25: 2463-2470, 2007.
20. Kawamoto R, Ohtsuka N, Ninomiya D, Nakamura S. Carotid atherosclerosis in normal-weight metabolic syndrome. Intern Med 46: 1771-1777, 2007.
21. Bai SS, Kuhurana D, Sharma A, Lai V, Bhansali A, Prabhakar S. Association of metabolic syndrome with carotid atherosclerosis in the young North Indian population. Diabetes Metab Syndr 5: 153-157, 2011.
22. Yin JH, Song ZY, Shan PF, et al. Age-and gender-specific prevalence of carotid atherosclerosis and its association with metabolic syndrome in Hangzhou, China. Clin Endocrinol (Oxf) 76: 802-809, 2012.
23. Abiko A, Makita S, Naganuma Y, Nagai M, Nakamura M. Association between metabolic syndrome and carotid atherosclerosis: relevance of combined criteria including the serum adiponectin level for the general population. Intern Med 50: 381-387, 2011.
24. Della-Morte D, Gardener H, Denaro F, et al. Metabolic syndrome increases carotid artery stiffness: the Northern Manhattan Study. Int J Stroke 5: 138-144, 2010.
25. Kwon HM, Kim BJ, Lee SH, Choi SH, Oh BH, Yoon BW. Metabolic syndrome as an independent risk factor of silent brain infarction in healthy people. Stroke 37: 466-470, 2006.
26. Kwon HM, Kim BJ, Park JH, et al. Significant association of metabolic syndrome with silent brain infarction in elderly people. J Neurol 256: 1825-1831, 2009.
27. Park K, Yasuda N, Toyonaga S, Tsubosaki E, Nakabayashi H, Shimizu K. Significant associations of metabolic syndrome and itscomponents with silent lacunar infarction in middle aged subjects. J Neurol Neurosurg Psychiatry 79: 719-721, 2008.
28. Kataoka Y, Wolski K, Uno K, et al. Spotty calcification as a marker of accelerated progression of coronary atherosclerosis: insights from serial intravascular ultrasound. J Am Coll Cardiol 59: 1592-1597, 2012.
29. Sekikawa A, Shin C, Curb JD, et al. Aortic stiffness and calcification in men in a population-based international study. Atherosclerosis 222: 473-477, 2012.
30. Hitsumoto T, Takahashi M, Iizuka T, Shirai K. Relationship between metabolic syndrome and early stage coronary atherosclerosis. J Atheroscler Thromb 14: 294-302, 2007.
31. Hoshino A, Nakamura T, Enomoto S, et al. Prevalence of coronary artery disease in Japanese patients with cerebral infarction: impact of metabolic syndrome and intracranial large artery atherosclerosis. Circ J 72: 404-408, 2008.
32. Yokoyama H, Kuramitsu M, Kanno S, Tada J, Yokota Y, Kamikawa F. Relationship between metabolic syndrome components and vascular properties in Japanese type 2 diabetic patients without cardiovascular disease or nephropathy. Diabetes Res Clin Pract 75: 200-206, 2007.
33. Snell-Bergeon JK, Roman R, Rodbard D, et al. Glycaemic variability is associated with coronary artery calcium in men with Type 1 diabetes: the coronary artery calcification in type 1 diabetes study. Diabet Med 27: 1436-1442, 2010.
34. Mannami T, Konishi M, Baba S, Nishi N, Terao A. Prevalence of asymptomatic carotid atherosclerotic lesions detected by highresolution ultrasonography and its relation to cardiovascular risk factors in the general population of a Japanese city. The Suita Study. Stroke 28: 518-525, 1997.